Your browser doesn't support javascript.
loading
Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and Beyond.
Matthew, Ashley N; Leidner, Florian; Lockbaum, Gordon J; Henes, Mina; Zephyr, Jacqueto; Hou, Shurong; Rao, Desaboini Nageswara; Timm, Jennifer; Rusere, Linah N; Ragland, Debra A; Paulsen, Janet L; Prachanronarong, Kristina; Soumana, Djade I; Nalivaika, Ellen A; Kurt Yilmaz, Nese; Ali, Akbar; Schiffer, Celia A.
Afiliación
  • Matthew AN; Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, United States.
  • Leidner F; Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, United States.
  • Lockbaum GJ; Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, United States.
  • Henes M; Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, United States.
  • Zephyr J; Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, United States.
  • Hou S; Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, United States.
  • Rao DN; Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, United States.
  • Timm J; Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, United States.
  • Rusere LN; Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, United States.
  • Ragland DA; Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, United States.
  • Paulsen JL; Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, United States.
  • Prachanronarong K; Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, United States.
  • Soumana DI; Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, United States.
  • Nalivaika EA; Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, United States.
  • Kurt Yilmaz N; Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, United States.
  • Ali A; Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, United States.
  • Schiffer CA; Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, United States.
Chem Rev ; 121(6): 3238-3270, 2021 03 24.
Article en En | MEDLINE | ID: mdl-33410674

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Proteínas Virales / Virosis / Preparaciones Farmacéuticas / Inhibidores Enzimáticos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Chem Rev Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Proteínas Virales / Virosis / Preparaciones Farmacéuticas / Inhibidores Enzimáticos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Chem Rev Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
...